In vitro and in vivo reversal of cancer cell multidrug resistance by the semi-synthetic antibiotic tiamulin

Biochemical Pharmacology

Volumn 56, Issue 9, 1998, Pages 1219-1228

  Baggetto, Loris G ^a   Dong, Maoqing ^d   Bernaud, Jeanine ^b   Espinosa, Leon ^c   Rigal, Dominique ^b   Bonvallet, Robert ^c   Marthinet, Eric ^a  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^b Etablissement de Transfus Sanguine   (France)

^c UMR 5578 CNRS Univ   (France)

^d MAYO CLINIC   (United States)

Author keywords

Flow cytometry; Multidrug resistance; P glycoprotein; Pleuromutilin; Reversion; Tiamulin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; TIAMULIN; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHATIC LEUKEMIA; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CALCIUM CHANNELS; DAUNORUBICIN; DITERPENES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; MALE; MICE; MICE, INBRED DBA; P-GLYCOPROTEIN; RATS; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0031773482     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00229-9     Document Type: Article

References (22)

1. Juliano R and Ling V, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455: 152-162, 1976.
2. Gros P, Ben Neriah YB, Croop JM and Housman DE, Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323: 728-731, 1986.
3. Ford JM and Hait VN, Pharmacologic circumvention of multidrug resistance. Cytotechnology 12: 171-212, 1993.
4. Georges E, Sharom FJ and Ling V, Multidrug resistance and chemosensitization: Therapeutic implications for cancer chemotherapy. Adv Pharmacol 21: 185-220, 1990.
5. Foxwell BMJ, Mackie A, Ling V and Ryffel B, Identification of the multiple resistance-related P-glycoprotein as a cyclosporine binding protein. Mol Pharmacol 36: 543-546, 1989.
6. Boesch D, Muller K, Pourtier-Manzanedo A and Loor F, Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZPSC 833, a nonimmunosuppressive cyclosporin derivative. Exp Cell Res 196: 26-32, 1991.
7. Baggetto LG and Lehninger AL, Formation and utilization of acetoin, an unusual product of pyruvate metabolism by Ehrlich and AS30-D tumor mitochondria. J Biol Chem 262: 9535-9541, 1987.
8. Adams RPL, Cell culture for biochemists. In: Laboratory Techniques in Biochemistry and Molecular Biology (Eds. Burdon RH and van Knippenberg PH), pp 179-182. Elsevier, Amstersdam, 1990.
9. Carmichael J, Degraff WG, Gazdar AF, Minna JD and Mitchell JB, Evaluation of a tetrazolium-base semi-automated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47: 936-944, 1987.
10. Dong M, Penin F and Baggetto LG, Efficient purification and reconstitution of P-glycoprotein for functional and structural studies. J Biol Chem 271: 28875-28883, 1996.
11. tol density in hypertrophied right ventricular cells by simulated high altitude in adult rats. J Mol Cell Cardiol 29: 193-206, 1997.
12. Hamill OP, Marty A, Neher E, Sakmann B and Sigworth FJ, Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Archiv 391: 85-100, 1981.
13. Anchel M, Chemical studies with pleuromutilin. J Biol Chem 199: 133-139, 1952.
14. Zamora JM, Pearce HL and Beck WT, Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 33: 454-462, 1988.
15. Klopman G, Shi LM and Ramu A, Quantitative structure-activity relationship of multidrug resistance reversal agents. Mol Pharmacol 52: 323-334, 1997.
16. Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D and Gekeler V, Expression of mdr1, mrp, topoisomerase II/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukemias. Br J Haematol 89: 356-363, 1995.
17. Zaman GJR, Flens MJ, Van Leusden, De Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P, The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Nat Acad Sci USA 91: 8822-8826, 1994.
18. Ford JM, Modulators of multidrug resistance. Hematol Oncol Clin North Am 9: 337-361, 1995.
19. m of the pump. Biochim Biophys Acta 1027: 116-122, 1990.
20. Tamai I and Safa AR, Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. J Biol Chem 265: 16509-16513, 1990.
21. Witkamp RF, Nijmeijer SM and van Miert AS, Cytochrome P-450 complex formation in rat liver by the antibiotic tiamulin. Antimicrob Agents Chemother 40: 50-54, 1996.
22. Nakajyo S, Hara Y, Hirano S, Agata N, Shimizu K and Urakawa N, Inhibitory effects of tiamulin on contractile and electrical responses in isolated thoracic aorta and cardiac muscle of guinea pigs. J Pharm Pharmacol 44: 731-736, 1992.